AA
Addison Advisors’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.63K | Hold |
188
| – | – | ﹤0.01% | 654 |
|
|
2025
Q1 | $8.24K | Hold |
188
| – | – | ﹤0.01% | 608 |
|
|
2024
Q4 | $8.08K | Hold |
188
| – | – | ﹤0.01% | 615 |
|
|
2024
Q3 | $8.34K | Hold |
188
| – | – | ﹤0.01% | 612 |
|
|
2024
Q2 | $7.48K | Hold |
188
| – | – | ﹤0.01% | 597 |
|
|
2024
Q1 | $8.11K | Hold |
188
| – | – | ﹤0.01% | 534 |
|
|
2023
Q4 | $7.83K | Hold |
188
| – | – | ﹤0.01% | 537 |
|
|
2023
Q3 | $7.47K | Hold |
188
| – | – | ﹤0.01% | 509 |
|
|
2023
Q2 | $7.71K | Hold |
188
| – | – | ﹤0.01% | 499 |
|
|
2023
Q1 | $7.71K | Hold |
188
| – | – | ﹤0.01% | 486 |
|
|
2022
Q4 | $7.7K | Hold |
188
| – | – | ﹤0.01% | 465 |
|
|
2022
Q3 | $8K | Hold |
188
| – | – | 0.01% | 463 |
|
|
2022
Q2 | $8K | Hold |
188
| – | – | ﹤0.01% | 463 |
|
|
2022
Q1 | $9K | Hold |
188
| – | – | ﹤0.01% | 494 |
|
|
2021
Q4 | $9K | Hold |
188
| – | – | 0.01% | 422 |
|
|
2021
Q3 | $9K | Hold |
188
| – | – | 0.01% | 315 |
|
|
2021
Q2 | $10K | Buy |
+188
| New | +$10K | 0.01% | 304 |
|
|
2020
Q4 | $10K | Buy |
+188
| New | +$10K | 0.01% | 292 |
|